These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23821276)

  • 1. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.
    Alcaraz-Estrada SL; Reichert ED; Padmanabhan R
    Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of self-replicating subgenomic dengue virus 4 (DENV4) replicon.
    Alcaraz-Estrada SL; Del Angel R; Padmanabhan R
    Methods Mol Biol; 2014; 1138():131-50. PubMed ID: 24696335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of subgenomic replicons of New York strain of West Nile virus.
    Shi PY; Tilgner M; Lo MK
    Virology; 2002 May; 296(2):219-33. PubMed ID: 12069521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.
    Rossi SL; Zhao Q; O'Donnell VK; Mason PW
    Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication.
    Lo MK; Tilgner M; Bernard KA; Shi PY
    J Virol; 2003 Sep; 77(18):10004-14. PubMed ID: 12941911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential high-throughput assay for screening inhibitors of West Nile virus replication.
    Lo MK; Tilgner M; Shi PY
    J Virol; 2003 Dec; 77(23):12901-6. PubMed ID: 14610212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.
    Fayzulin R; Scholle F; Petrakova O; Frolov I; Mason PW
    Virology; 2006 Jul; 351(1):196-209. PubMed ID: 16647099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging.
    Pijlman GP; Kondratieva N; Khromykh AA
    J Virol; 2006 Nov; 80(22):11255-64. PubMed ID: 16971441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
    Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the effects of alterations in the tick-borne encephalitis virus 3'-noncoding region on translation and RNA replication using reporter replicons.
    Hoenninger VM; Rouha H; Orlinger KK; Miorin L; Marcello A; Kofler RM; Mandl CW
    Virology; 2008 Aug; 377(2):419-30. PubMed ID: 18533218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.
    Anthony KG; Bai F; Krishnan MN; Fikrig E; Koski RA
    Antiviral Res; 2009 Jun; 82(3):166-8. PubMed ID: 19135091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cis-acting elements in the rubella virus subgenomic RNA that play a role in its translation.
    Pappas CL; Tzeng WP; Frey TK
    Arch Virol; 2006 Feb; 151(2):327-46. PubMed ID: 16172842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triaryl pyrazoline compound inhibits flavivirus RNA replication.
    Puig-Basagoiti F; Tilgner M; Forshey BM; Philpott SM; Espina NG; Wentworth DE; Goebel SJ; Masters PS; Falgout B; Ren P; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1320-9. PubMed ID: 16569847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.
    Liu WJ; Chen HB; Wang XJ; Huang H; Khromykh AA
    J Virol; 2004 Nov; 78(22):12225-35. PubMed ID: 15507609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication.
    Ong SP; Choo BG; Chu JJ; Ng ML
    Antiviral Res; 2006 Dec; 72(3):216-23. PubMed ID: 16870272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA elements within the 5' untranslated region of the West Nile virus genome are critical for RNA synthesis and virus replication.
    Li XF; Jiang T; Yu XD; Deng YQ; Zhao H; Zhu QY; Qin ED; Qin CF
    J Gen Virol; 2010 May; 91(Pt 5):1218-23. PubMed ID: 20016034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of West Nile pseudo-infectious reporter virus for antiviral screening.
    Zhang HL; Ye HQ; Deng CL; Liu SQ; Shi PY; Qin CF; Yuan ZM; Zhang B
    Antiviral Res; 2017 May; 141():38-47. PubMed ID: 28202375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes.
    Varnavski AN; Khromykh AA
    Virology; 1999 Mar; 255(2):366-75. PubMed ID: 10069962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.